Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 143.00
-2.00 (-1.38%)
May 14, 2025, 1:30 PM CST
Alar Pharmaceuticals Revenue
Alar Pharmaceuticals had revenue of 5.82M TWD in the twelve months ending March 31, 2025, down -98.76% year-over-year. In the year 2024, Alar Pharmaceuticals had annual revenue of 5.82M, down -98.76%.
Revenue
5.82M
Revenue Growth
-98.76%
P/S Ratio
1,642.15
Revenue / Employee
215.44K
Employees
27
Market Cap
9.55B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.33M |
| Pegavision | 6.69B |
| Lumosa Therapeutics | 43.59M |